KG LEGAL \ INFO
BLOG

Synthetic data generation: the technology and its legal framework in the EU and Poland

Publication date: November 16, 2026

Legal status as at 11 November 2026

Synthetic data, meaning text, images and tabular records produced by algorithms rather than collected from the real world, has moved from the research lab into everyday business use. It promises datasets that can be shared, tested and used to train AI without exposing real individuals. The law, however, does not accept that promise at face value. In 2026 the European Data Protection Board stated that synthetic data is not anonymous by default, the AI Act’s transparency duties for synthetic content began to apply, and Poland established its own AI supervisory authority. This article explains how synthetic data is generated and what legal conditions its generation and use must meet.

More

“For Research Use Only” Is Not a Legal Shieldgg

Publication date: November 16, 2026

Online sales of semaglutide and other active substances in Poland – regulatory exposure for sellers, marketplaces, advertisers and logistics operators

Vials of semaglutide and other peptides are sold online in Poland as “research chemicals” and delivered to parcel lockers without a prescription. The label is meant to keep the product outside pharmaceutical law. It does not: under EU and Polish law the classification of a product follows its presentation and its effect, not the seller’s disclaimer. For businesses, the practical question is therefore not whether this trade is legal, but who in the chain – seller, marketplace, advertiser, influencer, payment or logistics provider – carries the criminal, administrative and civil risk, and how quickly Polish enforcement tools are catching up.

More

Following the Money Through the Blockchain: Crypto Ponzi Schemes, Laundering Techniques and Legal Remedies in Poland

Publication date: November 12, 2026

A blockchain is a public ledger, yet the proceeds of crypto fraud still disappear every day. Using the AdBlast pyramid scheme, which according to press reports harmed up to 90,000 people and caused losses of around USD 32 million, we trace how investor money is moved from a “private wallet” to cash withdrawn at an ATM. We then look at the criminal, fiscal and regulatory tools available in Poland as of November 2026, a moment when MiCA’s transitional period has expired but Poland still has no national crypto-asset supervisor, and at what this means for victims seeking to recover their funds.

More

The EU Pharma Package – the most far-reaching reform of EU pharmaceutical law in two decades

Publication date: November 12, 2026

After three years of negotiations, the reform of EU pharmaceutical legislation is one step away from completion. A new regulation and a new directive will replace the current Community code and the EMA Regulation, reshaping data and market protection periods, the rules for orphan medicines, the Bolar exemption and supply obligations. Originator and generic companies alike will need to revisit their strategies, and Poland faces a thorough overhaul of its Pharmaceutical Law.

More

Cross-Border Marital Property Agreements

Publication date: November 11, 2026

What the Overdeck divorce teaches Polish advisers of wealthy international families

The divorce of Two Sigma co-founder John Overdeck, fought without a prenuptial agreement over a fortune estimated at around USD 8 billion, shows how quickly a private dispute can become a risk for a business, its partners and its investors. This study uses the case as a starting point to compare the New Jersey prenuptial agreement with the Polish marital property agreement (intercyza) and sets out what Polish law permits, what it prohibits and what should be negotiated when advising wealthy international families.

More

UP